To hear about similar clinical trials, please enter your email below

Trial Title: Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker

NCT ID: NCT05763511

Condition: Ovarian Neoplasms
Ovary Cancer
Ovarian Cysts

Conditions: Official terms:
Ovarian Neoplasms
Ovarian Cysts

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Summary: This project investigates circulating tumor DNA (ctDNA) in patients with suspected ovarian malignancy. We hypothesize that measurement of ctDNA in women with suspected ovarian cancer can improve the diagnostic efficiency for preoperative differentiation between benign and malignant masses. Specifically, we hope to determine the diagnostic efficiency of ctDNA alone and ctDNA in combination with imaging modalities (ultrasonography, MRI, PET-CT) and CA 125 for preoperative differentiation between benign and malignant adnexal masses. Based on this, we hope to develop an improved diagnostic algorithm. The mutational profile and relation to tumour type, stage, treatment response and prognosis will be explored. Analyses of blood and tissue samples will be used to examine the disease development and biology. Blood samples, tumour tissue and data on imaging modalities as well as CA 125 will be collected prospectively in consecutive women referred to Aarhus University Hospital.

Criteria for eligibility:

Study pop:
Patients referred due to suspected ovarian cancer

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Suspected ovarian neoplasm - Informed consent Exclusion Criteria: - Inability to give informed consent - Previous ovarian cancer diagnosis

Gender: Female

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Department of Gynaecology and Obstetrics, Aarhus University Hospital

Address:
City: Aarhus
Country: Denmark

Status: Recruiting

Contact:
Last name: Ina Marie Dueholm Hjorth, MD

Phone: +45 26192456

Start date: July 1, 2022

Completion date: May 4, 2029

Lead sponsor:
Agency: University of Aarhus
Agency class: Other

Collaborator:
Agency: Aarhus University Hospital
Agency class: Other

Source: University of Aarhus

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05763511

Login to your account

Did you forget your password?